| Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study C Garcia-Vidal, G Sanjuan, E Moreno-García, P Puerta-Alcalde, ... Clinical Microbiology and Infection 27 (1), 83-88, 2021 | 940 | 2021 |
| Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance G Martinez-Nadal, P Puerta-Alcalde, C Gudiol, C Cardozo, ... Clinical Infectious Diseases 70 (6), 1068-1074, 2020 | 116 | 2020 |
| Artificial intelligence to support clinical decision-making processes C Garcia-Vidal, G Sanjuan, P Puerta-Alcalde, E Moreno-García, ... EBioMedicine 46, 27-29, 2019 | 97 | 2019 |
| Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance C Garcia-Vidal, C Cardozo-Espinola, P Puerta-Alcalde, F Marco, A Tellez, ... PloS one 13 (6), e0199531, 2018 | 83 | 2018 |
| Clinical characteristics and prognosis of infections caused by OXA-48 carbapenemase-producing Enterobacteriaceae in patients treated with ceftazidime-avibactam C De la Calle, O Rodríguez, L Morata, F Marco, C Cardozo, ... International journal of antimicrobial agents 53 (4), 520-524, 2019 | 78 | 2019 |
| Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies P Puerta-Alcalde, C Cardozo, M Suárez-Lledó, O Rodríguez-Núñez, ... Clinical microbiology and infection 25 (4), 447-453, 2019 | 63 | 2019 |
| Bacterial co-infection at hospital admission in patients with COVID-19 E Moreno-García, P Puerta-Alcalde, L Letona, F Meira, G Dueñas, ... International Journal of Infectious Diseases 118, 197-202, 2022 | 61 | 2022 |
| Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain C Garcia-Vidal, A Cózar-Llistó, F Meira, G Dueñas, P Puerta-Alcalde, ... The Lancet Regional Health–Europe 3, 2021 | 56 | 2021 |
| Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa C Gudiol, A Albasanz-Puig, J Laporte-Amargós, N Pallarès, A Mussetti, ... Antimicrobial agents and chemotherapy 64 (4), 10.1128/aac. 02494-19, 2020 | 52 | 2020 |
| Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome B Torres, P Alcubilla, A Gonzalez-Cordon, A Inciarte, M Chumbita, ... International Journal of Infectious Diseases 104, 164-168, 2021 | 51 | 2021 |
| Evaluation of ceftazidime/avibactam for serious infections due to multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa O Rodríguez-Núñez, M Ripa, L Morata, C de la Calle, C Cardozo, C Fehér, ... Journal of global antimicrobial resistance 15, 136-139, 2018 | 46 | 2018 |
| Personalized therapy approach for hospitalized patients with coronavirus disease 2019 C Garcia-Vidal, E Moreno-García, M Hernández-Meneses, ... Clinical Infectious Diseases 74 (1), 127-132, 2022 | 43 | 2022 |
| Changing epidemiology of bloodstream infection in a 25-years hematopoietic stem cell transplant program: current challenges and pitfalls on empiric antibiotic treatment … P Puerta-Alcalde, C Cardozo, F Marco, M Suarez-Lledo, E Moreno, ... Bone Marrow Transplantation 55 (3), 603-612, 2020 | 43 | 2020 |
| Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19 C Garcia-Vidal, R Alonso, AM Camon, C Cardozo, L Albiach, D Agüero, ... Journal of Antimicrobial Chemotherapy 76 (12), 3296-3302, 2021 | 39 | 2021 |
| Tocilizumab is associated with reduced risk of ICU admission and mortality in patients with SARS-CoV-2 infection E Moreno-García, V Rico, L Albiach, D Agüero, J Ambrosioni, M Bodro, ... medRxiv, 2020.06. 05.20113738, 2020 | 38 | 2020 |
| Can artificial intelligence improve the management of pneumonia M Chumbita, C Cillóniz, P Puerta-Alcalde, E Moreno-García, G Sanjuan, ... Journal of clinical medicine 9 (1), 248, 2020 | 37 | 2020 |
| Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection D Viasus, P Puerta-Alcalde, C Cardozo, M Suárez-Lledó, ... Clinical Microbiology and Infection 26 (3), 345-350, 2020 | 36 | 2020 |
| Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation P Puerta-Alcalde, C Garcia-Vidal Journal of Fungi 7 (10), 848, 2021 | 33 | 2021 |
| Impact of empirical antibiotic regimens on mortality in neutropenic patients with bloodstream infection presenting with septic shock M Chumbita, P Puerta-Alcalde, C Gudiol, N Garcia-Pouton, ... Antimicrobial Agents and Chemotherapy 66 (2), e01744-21, 2022 | 32 | 2022 |
| Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn) J Salmanton-Garcia, D Seidel, P Koehler, SC Mellinghoff, R Herbrecht, ... Journal of Antimicrobial Chemotherapy 74 (11), 3315-3327, 2019 | 32 | 2019 |
Alex SorianoConsultor del Servei de Malalties Infeccioses, Hospital ClínicVerified email at clinic.cat
